Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd, a subsidiary of the global healthcare leader Novartis AG, is headquartered in Australia and operates extensively across the Asia-Pacific region. Founded in 1996, the company has established itself as a key player in the pharmaceutical industry, focusing on innovative medicines and advanced therapies that address critical health needs.
Specialising in areas such as oncology, cardiology, and immunology, Novartis is renowned for its commitment to research and development, delivering unique products that enhance patient outcomes. The company’s portfolio includes groundbreaking treatments that have transformed the landscape of modern medicine, solidifying its market position as a trusted provider of high-quality pharmaceuticals.
With a strong emphasis on sustainability and access to healthcare, Novartis Pharmaceuticals Australia continues to achieve notable milestones, contributing significantly to the advancement of medical science and patient care in Australia and beyond.
+65 vs industry average
Novartis Pharmaceuticals Australia Pty Ltd.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Novartis Pharmaceuticals Australia Pty Ltd.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Retail Trade Services has below-average carbon intensity
Industry performance
The Retail Trade Services industry has reduced its overall emissions by 42% since 2019
Reported emissions
No reported emissions data is available for Novartis Pharmaceuticals Australia Pty Ltd. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Novartis Pharmaceuticals Australia Pty Ltd.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Novartis Pharmaceuticals Australia Pty Ltd. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novartis AG
Carbon Disclosure Project
Inherited from Novartis AGThe Climate Pledge
Inherited from Novartis AGUN Global Compact Climate Champions initiative
RE 100
Inherited from Novartis AGClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Novartis Pharmaceuticals Australia Pty Ltd. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project